PKM and neoplasm: In the mitochondria, PKM2 interacts with Bcl2 and phosphorylates it at threonine (T) 69, thus preventing Cul3-RBX1 ligase-mediated degradation of Bcl2, ultimately enhancing apoptosis resistance of tumour cells.